Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · November 28, 2022

Prehospital Transdermal Glyceryl Trinitrate Treatment in Patients With Presumed Acute Stroke

The Lancet Neurology


Additional Info

The Lancet Neurology
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial
Lancet Neurol 2022 Nov 01;21(11)971-981, SA van den Berg, SM Uniken Venema, H Reinink, J Hofmeijer, WJ Schonewille, I Miedema, PSS Fransen, DM O Pruissen, TWM Raaijmakers, GW van Dijk, FE de Leeuw, JA van Vliet, VIH Kwa, H Kerkhoff, A van 't Net, R Boomars, A Siegers, T Lok, K Caminada, LM Esteve Cuevas, MC Visser, CP Zwetsloot, JMF Boomsma, MH Schipper, RPJ van Eijkelenburg, OA Berkhemer, D Nieboer, HF Lingsma, BJ Emmer, RJ van Oostenbrugge, A van der Lugt, YBWEM Roos, CBLM Majoie, DWJ Dippel, PJ Nederkoorn, HB van der Worp

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading